Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
Clinical trial NCT05710224 · COMPLETED
Trial details
- NCT number
- NCT05710224
- Sponsor
- Butantan Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2024-01-22
- Enrollment
- 1364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.